Identification of a periplasmic dimethylsulfoxide reductase in hyphomicrobium EG grown under chemolithoheterotrophic conditions with dimethylsulfoxide as carbon source
The post's table puts the baseline headache rate in control arms at roughly three to five percent, against higher rates in the treatment rows, and concludes the medications raise relative risk modestly
PMID: 24428901
Diab Obes Metab 1(9):823385 Tizianello A, Deferrari G, Garibotto G, Robaudo C, Acquarone N, Ghiggeri GM (1982) Renal ammoniagenesis in an early stage of metabolic acidosis in man
For patients using Wegovy, substantial weight loss of around 10% or more of initial body weight can be seen after 6 to 12 months of consistent treatment
Patients interested in naltrexone-GLP-1 therapy should discuss recent literature with their prescribing physician and expect careful monitoring if the combination is initiated